Komori
Fuso Pharmaceutical Industries (4538) · InitiativeHuman-resources development measures made more specific

Enhancing Expertise Through Talent Development and Reskilling

First written in FY2023. 1 of 3 entries say "Restated". Latest entry: FY2026.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023 – FY20262023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Building a foundation for capability development through reforms to talent definitions and evaluation systemsA theme 176 companies write about · 0 as a headwind · 181 as a tailwind

7 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 176 companies compared. The sentences above are computed from all 176.
Full recordFilings, disclosures and news, newest first
  1. FY2026Human-resources development measures made more specificAnnual report

    「To achieve both sustainable enhancement of corporate value and employees’ self-fulfillment, we will support the acquisition and development of the skills and capabilities required for work and self-development. Specifically, in addition to expanding support for obtaining qualifications and promoting job rotation, we will expand our internal awards program and establish an environment for proposals to improve operations. Through these initiatives, we will encourage voluntary learning, challenges and employee participation, improve motivation, and support employees’ career development. We will also strengthen the acquisition of knowledge in specialized fields and incorporate this systematically into individual career plans, pursuing continuous talent development that includes reskilling opportunities.」

    In addition to its existing training and reskilling policy, the company disclosed specific measures including support for obtaining qualifications, job rotation, an internal awards program, proposals for operational improvements, and the acquisition of specialized knowledge.
  2. FY2024RestatedAnnual report

    「Going forward, we will incorporate these training programs into each employee’s career plan in a planned and systematic manner. Including the provision of reskilling opportunities, we will continuously develop our talent while pursuing both the realization of employees’ career visions and the enhancement of corporate value.」

    The company continues its talent development policy, including training by job function, seniority and position, next-generation leadership training, acquisition of specialized knowledge, and reskilling.
  3. FY2023First statedAnnual report

    「In addition to training for acquiring the skills required for work, we place emphasis on training for self-development. We also provide training aimed at acquiring the capabilities required for each department, level of service, position and job function, including fourth-year employee training and next-generation leadership training. Going forward, we will incorporate these training programs into each employee’s career plan in a planned and systematic manner. Including the provision of reskilling opportunities, we will continuously develop our talent while pursuing both the realization of employees’ career visions and the enhancement of corporate value.」

    Training tailored to job function, seniority and position, next-generation leadership training, and reskilling are described as initiatives related to human capital.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Expertise Through Talent Development and Reskilling | Fuso Pharmaceutical Industries,Ltd. (4538) | Komori